Ryota Nishimori
President chez CAC HOLDINGS CORPORATION
Fortune : 623 212 $ au 31/03/2024
Profil
Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAC HOLDINGS CORPORATION
0,23% | 31/12/2022 | 48 000 ( 0,23% ) | 623 212 $ | 31/03/2024 |
Postes actifs de Ryota Nishimori
| Sociétés | Poste | Début |
|---|---|---|
| CAC HOLDINGS CORPORATION | President | 01/01/2021 |
CAC KK
 CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | President | 01/04/2014 |
Anciens postes connus de Ryota Nishimori
| Sociétés | Poste | Fin |
|---|---|---|
| CAC America Corp. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CAC HOLDINGS CORPORATION | Technology Services |
| Entreprise privées | 2 |
|---|---|
| CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |
